Bio Preventive Medicine Corp. (TPEX:6810)

Market Cap	1.49B +26.7%
Revenue	n/a
Net Income	n/a
EPS	n/a
Shares Out	49.45M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	373,586
Open	28.70
Previous Close	29.05
Day's Range	28.70 - 30.65
52-Week Range	16.50 - 46.00
Beta	0.50
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About Bio Preventive Medicine

Bio Preventive Medicine Corp., a clinical-staged biotech company, focusing on early detection and prevention of diseases. The company offers solutions in prevention, screening, and monitoring chronic diseases and cancers management. It also provides DNlite test, a series of patented and clinically validated non-invasive urine test for monitoring the progression of diabetic nephropathy, including DNlite-IVD103 and DNlite-DN_Score. Bio Preventive Medicine Corp. was founded in 2014 and is headquartered in Zhubei, Taiwan.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2014
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 6810